A 29-year-old man with multiple sclerosis.
作者信息
Rudick R A
机构信息
Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Ohio State University, USA.
出版信息
JAMA. 1998 Oct 28;280(16):1432-9. doi: 10.1001/jama.280.16.1432.
PMID:9801004
Abstract
摘要
相似文献
1
A 29-year-old man with multiple sclerosis.
JAMA. 1998 Oct 28;280(16):1432-9. doi: 10.1001/jama.280.16.1432.
2
[Multiple sclerosis (MS), an inflammatory or degenerative disease?].
Presse Med. 2004 Feb 14;33(3):151-2. doi: 10.1016/s0755-4982(04)98510-7.
3
Newer long-term treatments for multiple sclerosis.多发性硬化症的新型长期治疗方法。
Clin Neurol Neurosurg. 2002 Jul;104(3):265-71. doi: 10.1016/s0303-8467(02)00050-1.
4
Guidance on new therapies in multiple sclerosis patients.
Lancet. 1996 Jul 13;348(9020):136. doi: 10.1016/s0140-6736(05)64657-0.
5
[Problems and prospects of beta-interferon and copaxone++ application in the treatment of multiple sclerosis].β-干扰素和考帕松++在多发性硬化症治疗中的应用问题与前景
Zh Nevrol Psikhiatr Im S S Korsakova. 1999;99(4):33-6.
6
[Recommendations for the use of immunomodulatory drugs in multiple sclerosis: the BCTRIMS consensus] [Brazilian Committee for Treatment and Research in Multiple Sclerosis].[巴西多发性硬化症治疗与研究委员会关于免疫调节药物在多发性硬化症中应用的建议：BCTRIMS 共识]
Arq Neuropsiquiatr. 2000 Sep;58(3A):769-76. doi: 10.1590/s0004-282x2000000400030.
7
[Interferon beta-1b in multiple sclerosis--news regarding open questions].[干扰素β-1b治疗多发性硬化症——关于未解决问题的新闻]
Nervenarzt. 1997 Aug;68(8 Suppl Interferon):1-4.
8
Glatiramer and suspected multiple sclerosis. No proven advantage.格拉替雷与疑似多发性硬化症。无已证实的优势。
Prescrire Int. 2010 Aug;19(108):160.
9
To treat, or not to treat: the therapeutic dilemma of idiopathic monosymptomatic demyelinating syndromes.治疗还是不治疗：特发性单症状脱髓鞘综合征的治疗困境
Arch Neurol. 2000 Jul;57(7):930-2. doi: 10.1001/archneur.57.7.930.
10
More immunotherapy for multiple sclerosis.更多用于治疗多发性硬化症的免疫疗法。
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):239-41. doi: 10.1136/jnnp.61.3.239.
Zotero 插件